Results 111 to 120 of about 5,594 (186)

PUK5 ANÁlisis Comparativo De Costos Del Tratamiento Para La Anemia Renal Con Metoxi POLIETILENGLICOL-Eritropoyetina Beta (MIRCERA®) VS. Eritropoyetina ALFA [PDF]

Value in Health, 2011
openaire   +1 more source

[Thrombotic Risk and Covid-19: Review of Current Evidence for a Better Diagnostic and Therapeutic Approach]. [PDF]

Arch Bronconeumol, 2021
López-Reyes R, Oscullo G, Jiménez D, Cano I, García-Ortega A.   +4 more
europepmc   +1 more source

Influence of NeuroEPO on the fetal-placental development of rats in a model of placental insufficiency

Revista Habanera de Ciencias Médicas
Introduction: Placental insufficiency is the most common cause of intrauterine growth retardation (IUGR). This condition requires new strategies that will make it possible to reduce hypoxia and fetal-placental malnutrition.
Ninive Núñez López, Vivian Tejeda Borjas, Yainet Cruz Álvarez, Yordanca Morgado Gamboa, Sebastián Andrés San Martin Henríquez   +4 more
doaj  

Enfermedad renal quística adquirida y su relación con variables clínicas, demográficas y antropométricas en pacientes dialíticos

Revista Cubana de Medicina
Introducción: la enfermedad renal crónica (ERC) se asocia frecuentemente con enfermedad renal quística adquirida (ERQA). En el orden clínico, esta última suele ser asintomática, pero puede complicarse con carcinoma renal.
Raymed Antonio Bacallao Méndez, Arturo Ávila Guzmán, Jennie Salgado López, Francisco Gutiérrez García, Betsy Llerena Ferrer   +4 more
doaj  

Iron status and hemoglobin adjustment by altitude to define anemia in children aged 6 to 8 months living in Lima, Arequipa, Cusco and Puno. [PDF]

Rev Peru Med Exp Salud Publica, 2023
Aparco JP, Santos-Antonio G, Bautista-Olortegui W, Alvis-Chirinos K, Velarde-Delgado P, Hinojosa-Mamani P, Solis-Sanchez G, Santa Cruz FE, Zavaleta N.   +8 more
europepmc   +1 more source

Knowledge-based clinical decision support system for the automated classification of anemia in hemodialysis patients [PDF]

Biomedica
Tenorio S, Valderrama LA, Arango-Álvarez JJ, Lozano LA, Mojica IL.   +4 more
europepmc   +1 more source

Uso de Eritropoyetina Temprana vs Tardía, para la Reducción de Transfusiones Sanguíneas en Prematuros de la UCIN, del Hospital General de Tlalnepantla 2010 - 2012 [PDF]

, 2013
Mancilla Sánchez, Octavio Rafael
core  

Mecanismos involucrados en la resistencia celular a la acción de eritropoyetina

, 2020
Erythropoietin (Epo) is a glycoprotein belonging to the cytokine family which is produced in adult kidneys. Its main actions are to induce proliferation, survival and differentiation of erythroid progenitors. Anemia, caused by low levels of Epo in the bloodstream due to a reduced functional renal mass, is one of the main conditions that affect the life
openaire   +2 more sources

[Comment on the article "Erythrocyte morphological alterations as predictors of kidney injury severity"]. [PDF]

Rev Med Inst Mex Seguro Soc
Feria-Ramírez JA.
europepmc   +1 more source

[Considerations on hypoxia and altitude]. [PDF]

Rev Med Inst Mex Seguro Soc
Santos-Martínez LE.
europepmc   +1 more source